✨ Your Portfolio is fetched and updated from zerodha.
Small
Market Cap
₹2,938 Cr.
P/E
41.61

Key Ratios

Market cap
Market cap
2,938 Cr
PE
PE
41.61
Prom Holding
Prom Holding
-
ROE (%)
ROE (%)
17.78
ROCE (%)
ROCE (%)
22.95
Div Yield (%)
Div Yield (%)
0.35
Sales
Sales
363 Cr
OPM (%)
OPM (%)
35.20 %
Debt to Equity
Debt to Equity
-
About
Vimta Labs is in the Miscellaneous sector with a M.cap of 2938.00 Cr and a PE ratio of… Read more
Low
52W Range
High

Insufficient data

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

0 Yes

Positive for this company

0 Neutral

Neutral for this company

0 No

Negative for this company

0 No Data

Insufficient data to analyse

Peer Comparison
FAQs on Vimta Labs Ltd. Business

Founded in 1984, Vimta Labs Limited provides analytical, clinical, and preclinical services to life sciences industries, quality testing for food and beverage sectors, and environmental services globally.

Vimta Labs major competitors are Krsnaa Diagnostics, Nidan Labs. & Health, Thyrocare Tech., Vijaya Diagnostic, Metropolis Health., Dr. Lal Pathlabs, Amrutanjan Healthcar.
Market Cap of Vimta Labs is ₹2,920 Crs.
While the median market cap of its peers are ₹6,833 Crs.

Vimta Labs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release Mar Jul Mar Jun Sep Dec Mar Jun Sep Dec
Investor Presentation Apr Jul Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Mar Jun Sep Mar Jun Sep Dec Mar Sep Dec Mar Sep Mar Sep Dec Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material